Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Mon, 08/03/2020 - 03:15	Opened		Анонимен
Newsletter opened	Mon, 08/03/2020 - 03:15	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%AF%B8%EA%B0%80%EA%B3%B5-%EB%8D%B0%EC%9D%B4%ED%84%B0%EB%A5%BC-%EC%8B%A4%EC%A7%88%EC%A0%81-%EC%A7%80%EC%8B%9D%EC%9C%BC%EB%A1%9C-%EC%A0%84%ED%99%98%ED%95%98%EB%8A%94-%EB%A8%B8%EC%8B%A0%EB%9F%AC%EB%8B%9D		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias motivacionais para combater o estigma	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Apoio à saúde mental em tempos de crise	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter clicked	Sun, 08/02/2020 - 17:29	Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81		Анонимен
Newsletter opened	Sun, 08/02/2020 - 17:29	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Mon, 08/03/2020 - 03:15	Opened		Анонимен
Newsletter opened	Mon, 08/03/2020 - 03:15	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://korea.progress.im/ko/content/%EB%AF%B8%EA%B0%80%EA%B3%B5-%EB%8D%B0%EC%9D%B4%ED%84%B0%EB%A5%BC-%EC%8B%A4%EC%A7%88%EC%A0%81-%EC%A7%80%EC%8B%9D%EC%9C%BC%EB%A1%9C-%EC%A0%84%ED%99%98%ED%95%98%EB%8A%94-%EB%A8%B8%EC%8B%A0%EB%9F%AC%EB%8B%9D		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Mantenha-se atualizado em apenas 5 minutos sobre Psiquiatria e Neurologia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias motivacionais para combater o estigma	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Apoio à saúde mental em tempos de crise	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Анонимен
Newsletter clicked	Sun, 08/02/2020 - 17:29	Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81		Анонимен
Newsletter opened	Sun, 08/02/2020 - 17:29	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER